Shopping Cart 0
Cart Subtotal
USD 0

PharmSource-Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook-2017 Edition

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 2995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 5990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 8985

Details

PharmSource-Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook-2017 Edition

Summary

This report provides an important expert quantitative analysis on the contract dose manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Founded on the industry's most comprehensive database of the dose CMO industry (PharmSource's Strategic Advantage Database of Contract Service Providers) this analysis is driven by our proprietary model of the dose manufacturing industry, which is continuously updated and refined. The model and assumptions are fully explained so readers can understand how the analysis and conclusions have been established.

This 29-page report includes an Executive Summary and chapters on Industry Size and Structure, Industry Size and Growth, CMO Market Shares and concludes with a chapter on The Outlook for the Dose CMO Industry, which provides further analysis and assesses the report's implications for the dose CMO industry. In addition, it includes an appendix on methodology.

Scope

This report characterizes the contract dose manufacturing industry along a number of quantitative dimensions, including number and type of participants, market size and market shares of the top CMOs, and provides PharmSource's expert outlook for the industry.

The contract dose manufacturing universe, for purposes of this report, includes companies that actively promote themselves as contract manufacturers (CMOs) that produce a client's formulations for pharmaceuticals supplied to the highly regulated markets in North America, Europe and Japan.

The report defines the contract dose manufacturing universe as including 282 companies headquartered primarily in North America, Europe, Japan and India.

Reasons to buy

The expertise and skilled analysis in this 29-page report gives important insight you won't find in any other source. This report is required reading for-

CMO executives and strategic decision-makers: you'll find this report an indispensable resource for understanding the industry and a critical input for strategic planning efforts.

Sourcing and procurement executives in bio/pharmaceutical companies: you'll find the report a critical resource for understanding crucial components of the supply base that will provide insights for supplier selection and management.

Private equity investors: you'll get a deeper understanding of the market and important insight for identifying potential investment targets.

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary

Industry Size and Structure

Major Developments Affecting Industry Structure

Industry Size and Growth

CMO Market Shares

Analyzing Recent Dose CMO Industry Performance

Appendix


List Of Figure

List of Figures

Figure 1 Geographic Reach of Dose CMO Universe

Figure 2 Distribution of Dose CMOs by Revenue (Number of CMOs)

Figure 3 Dose CMO Market Size 2009-2016

Figure 4 Components of Growth 2015-2016

Figure 5 Dose CMO Dosage Form Segments ($ Billion)

Figure 6 Dose CMO Industry Market Share by Company Size

Figure 7 Bio/Pharma Services Sector Performance

Figure 8 Organic Revenue Growth for Public CMOs

Figure 9 Breakdown of NMEs & Outsourced MNEs Approved for Global Bio/Pharma Companies 2007-2016

Figure 10 Breakdown of US Orphan Drug Approvals 2010-2016


List Of Table

List of Tables

Table 1 CMO Facility Acquisition Activity 2011-2016

Table 2 CMO Acquisitions of Bio/Pharmaceutical Company Facilities 2016

Table 3 CMOs Acquisitions of Other CMOs 2016

Table 4 Private Equity Investments in the Dose CMO Industry 2012-2016

Table 5 Revenue Composition and Strategic Orientation of Leading CMOs 2016

Table 6 Companies Included in Dose CMO Universe

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

PharmSource-Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook-2017 Edition

Summary

This report provides an important expert quantitative analysis on the contract dose manufacturing industry. PharmSource is the most definitive, trustworthy source of strategic insight on this topic in the bio/pharmaceutical realm.

Founded on the industry's most comprehensive database of the dose CMO industry (PharmSource's Strategic Advantage Database of Contract Service Providers) this analysis is driven by our proprietary model of the dose manufacturing industry, which is continuously updated and refined. The model and assumptions are fully explained so readers can understand how the analysis and conclusions have been established.

This 29-page report includes an Executive Summary and chapters on Industry Size and Structure, Industry Size and Growth, CMO Market Shares and concludes with a chapter on The Outlook for the Dose CMO Industry, which provides further analysis and assesses the report's implications for the dose CMO industry. In addition, it includes an appendix on methodology.

Scope

This report characterizes the contract dose manufacturing industry along a number of quantitative dimensions, including number and type of participants, market size and market shares of the top CMOs, and provides PharmSource's expert outlook for the industry.

The contract dose manufacturing universe, for purposes of this report, includes companies that actively promote themselves as contract manufacturers (CMOs) that produce a client's formulations for pharmaceuticals supplied to the highly regulated markets in North America, Europe and Japan.

The report defines the contract dose manufacturing universe as including 282 companies headquartered primarily in North America, Europe, Japan and India.

Reasons to buy

The expertise and skilled analysis in this 29-page report gives important insight you won't find in any other source. This report is required reading for-

CMO executives and strategic decision-makers: you'll find this report an indispensable resource for understanding the industry and a critical input for strategic planning efforts.

Sourcing and procurement executives in bio/pharmaceutical companies: you'll find the report a critical resource for understanding crucial components of the supply base that will provide insights for supplier selection and management.

Private equity investors: you'll get a deeper understanding of the market and important insight for identifying potential investment targets.

READ MORE

Scope

Table of Contents

Executive Summary

Industry Size and Structure

Major Developments Affecting Industry Structure

Industry Size and Growth

CMO Market Shares

Analyzing Recent Dose CMO Industry Performance

Appendix


List Of Figure

List of Figures

Figure 1 Geographic Reach of Dose CMO Universe

Figure 2 Distribution of Dose CMOs by Revenue (Number of CMOs)

Figure 3 Dose CMO Market Size 2009-2016

Figure 4 Components of Growth 2015-2016

Figure 5 Dose CMO Dosage Form Segments ($ Billion)

Figure 6 Dose CMO Industry Market Share by Company Size

Figure 7 Bio/Pharma Services Sector Performance

Figure 8 Organic Revenue Growth for Public CMOs

Figure 9 Breakdown of NMEs & Outsourced MNEs Approved for Global Bio/Pharma Companies 2007-2016

Figure 10 Breakdown of US Orphan Drug Approvals 2010-2016


List Of Table

List of Tables

Table 1 CMO Facility Acquisition Activity 2011-2016

Table 2 CMO Acquisitions of Bio/Pharmaceutical Company Facilities 2016

Table 3 CMOs Acquisitions of Other CMOs 2016

Table 4 Private Equity Investments in the Dose CMO Industry 2012-2016

Table 5 Revenue Composition and Strategic Orientation of Leading CMOs 2016

Table 6 Companies Included in Dose CMO Universe

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS